Jakobsen Rasmus Peter, Hansen Elisabeth Charlotte, Nielsen Troels Halfeld, Nordström Carl-Henrik, Toft Palle
Department of Anaesthesiology and Intensive Care, Odense University Hospital, J.B. Winsløws Vej 4, indgang 8, indgang 5, Penthouse/2, 20, 201, 5000, Odense C, Denmark.
Faculty of Health Sciences, University of Southern Denmark, J.B. Winsløws Vej 19 3, 5000, Odense C, Denmark.
Intensive Care Med Exp. 2022 Feb 4;10(1):4. doi: 10.1186/s40635-022-00432-z.
The use of norepinephrine in the case of life-threatening haemorrhagic shock is well established but widely discussed. The present study was designed to compare the effects of early norepinephrine treatment vs. no treatment on cerebral energy metabolism during haemorrhagic shock.
Twelve pigs were subjected to haemorrhagic shock, 4 in the control group and 8 in the norepinephrine (NE) group. Following a 60 min baseline period haemorrhagic shock was achieved by bleeding all animals to a pre-defined mean arterial blood pressure (MAP) of approximately 40 mm Hg. When mean arterial pressure had decreased to 40 mmHg NE infusion started in the treatment group. After 90 min, NE infusion stopped, and all pigs were resuscitated with autologous blood and observed for 2.5 h. During the experiment cerebral tissue oxygenation (PbtO) was monitored continuously and variables reflecting cerebral energy metabolism (glucose, lactate, pyruvate, glutamate, glycerol) were measured by utilizing intracerebral microdialysis.
All 12 pigs completed the protocol. NE infusion resulted in significantly higher MAP (p < 0.001). During the shock period lactate/pyruvate (LP) ratio group increased from 20 (15-29) to 66 (38-82) (median (IQR)) in the control group but remained within normal limits in the NE group. The significant increase in LP ratio in the control group remained after resuscitation. After induction of shock PbtO decreased markedly in the control group and was significantly lower than in the NE group during the resuscitation phase.
NE infusion during haemorrhagic shock improved cerebral energy metabolism compared with no treatment.
去甲肾上腺素在危及生命的失血性休克治疗中的应用已得到充分证实,但仍存在广泛争议。本研究旨在比较早期去甲肾上腺素治疗与不治疗对失血性休克期间脑能量代谢的影响。
12头猪接受失血性休克实验,对照组4头,去甲肾上腺素(NE)组8头。在60分钟的基线期后,通过将所有动物放血至预先定义的平均动脉血压(MAP)约40 mmHg来诱导失血性休克。当平均动脉压降至40 mmHg时,治疗组开始输注NE。90分钟后,停止输注NE,所有猪用自体血进行复苏,并观察2.5小时。实验期间,连续监测脑组织氧合(PbtO),并利用脑内微透析测量反映脑能量代谢的变量(葡萄糖、乳酸、丙酮酸、谷氨酸、甘油)。
所有12头猪均完成实验方案。输注NE导致MAP显著升高(p < 0.001)。在休克期,对照组的乳酸/丙酮酸(LP)比值从20(15 - 29)增加到66(38 - 82)(中位数(四分位间距)),而NE组保持在正常范围内。复苏后,对照组LP比值仍显著升高。休克诱导后,对照组的PbtO显著下降,在复苏阶段显著低于NE组。
与不治疗相比,失血性休克期间输注NE可改善脑能量代谢。